New Jersey 2026-2027 Regular Session

New Jersey Senate Bill S3262

Introduced
2/2/26  

Caption

Requires health insurers to cover Lyme disease.

Impact

The implementation of S3262 is expected to significantly influence the landscape of health insurance in New Jersey, particularly for those affected by Lyme disease. By ensuring that coverage includes medically necessary treatments, the bill aims to alleviate the financial burden often associated with chronic Lyme disease care. Moreover, it could encourage more healthcare providers to offer or recommend treatments that were previously relegated to 'investigational' status due to insurance constraints. Thus, this bill could lead to improved health outcomes for patients with Lyme disease.

Summary

Senate Bill 3262 mandates that health insurers in New Jersey provide coverage for the treatment of Lyme disease. This encompasses various types of health insurance contracts including those offered by hospital service corporations, medical service corporations, health maintenance organizations, and others. The bill emphasizes that treatment classified as experimental or investigational cannot be used as a basis to deny coverage for services that are deemed medically necessary by the patient's physician. This provision is crucial for ensuring that patients receive necessary treatments without the fear of denied claims under their health plans.

Contention

While S3262 has the potential to benefit many, it may also be met with opposition due to concerns from insurance companies about the implications of extending coverage for treatments that may not universally be accepted within the medical community. Critics may argue that labeling treatments as medically necessary can create challenges in defining coverage boundaries and could lead to increased premiums. Moreover, there could be concern over the costs associated with ensuring that all types of insurance contracts comply with this mandate as it may place additional financial strain on health insurers.

Companion Bills

NJ S926

Carry Over Requires health insurers to cover Lyme disease.

Similar Bills

AZ HB2944

Inpatient treatment days; computation; exclusion

CA AB1879

Substance use: treatment or residential data reporting.

AZ SB1244

Court-ordered treatment; continuation

CA AB2538

Medi-Cal: hospice providers: forms.

AZ HB2706

Mental health; intensive treatment orders

IA HF326

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)

IA HF518

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)

OK HB3587

Mental health; authorizing court-ordered outpatient treatment; effective date.